Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LianBio - American Depositary Shares (NQ:LIAN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about LianBio - American Depositary Shares

< Previous 1 2 3 4 Next >
News headline image
What's Going On With LianBio (LIAN) Stock? ↗
LianBio shares are trading higher by some 84% to $0.35 Friday afternoon on continued volatility. The company in late February announced its intent to delist its ADSs from the Nasdaq Global Market. 
Via Benzinga
News headline image
Why Is LianBio (LIAN) Stock Moving Today? ↗
LianBio stock is incredibly volatile on Friday as heavy trading rocks LIAN amid plans for a voluntary delisting of the shares. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
It's time to start the final day of trading this week with a look into the biggest pre-market stock movers for Friday morning! 
Via InvestorPlace
News headline image
LianBio Announces Voluntarily Delisting from Nasdaq
From LianBio
Via GlobeNewswire
News headline image
B of A Securities Downgrades LianBio: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Why LianBio Stock Is Skyrocketing Today ↗
Investors are loving LianBio's new deal with Bristol Myers Squibb. 
Via The Motley Fool
News headline image
Week In Review: LianBio To Close Operations; Will Pay $528 Million To Shareholders ↗
LianBio, a Princeton-Shanghai biotech, has decided to call it quits. LianBio plans to stop all of its operations by the end of 2024, and it will distribute a $4.80 dividend/share ($528 million) to its... 
Via Talk Markets
News headline image
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance. 
Via Benzinga
News headline image
Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
LianBio Announces Completion of Strategic Review
LianBio to commence the wind down of its operations, including sale of remaining assets and reduction in force, delisting from Nasdaq and issuance of special cash dividend 
From LianBio
Via GlobeNewswire
News headline image
Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal ↗
Shanghai’s Elpiscience Biopharma has formed a $1.7 billion collaboration with Japan’s Astellas Pharma to develop a novel bispecific macrophage engager, ES019, along with an unspecified program.... 
Via Talk Markets
News headline image
LianBio Enters into Agreement Assigning its Rights for NBTXR3 in China and Other Asian Markets
From LianBio
Via GlobeNewswire
News headline image
LianBio Announces Departure of Chief Financial Officer
From LianBio
Via GlobeNewswire
News headline image
LianBio Announces Departure of Chief Executive Officer
From LianBio
Via GlobeNewswire
News headline image
LianBio’s Board of Directors Unanimously Determines not to Pursue Unsolicited Proposal from Concentra Biosciences
From LianBio
Via GlobeNewswire
News headline image
Week In Review: Tang Capital Offers $465 Million For LianBio Plus 80% Of Any Licenses/Divestments ↗
LianBio received a $465 million buyout offer from Tang Capital Management. In addition, Tang also offered shareholders a contingent value right for 80% of net proceeds from any license or divestment of... 
Via Talk Markets
News headline image
LianBio Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
From LianBio
Via GlobeNewswire
News headline image
LianBio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
From LianBio
Via GlobeNewswire
News headline image
LianBio Announces Topline Results from Phase 3 LIBRA Trial of TP-03 in Chinese Patients with Demodex Blepharitis
From LianBio
Via GlobeNewswire
News headline image
ArcelorMittal, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
News headline image
Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal ↗
Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its... 
Via Talk Markets
News headline image
Why LianBio Stock Is Shooting Through the Roof This Week ↗
LianBio stock is seeing explosive gains, and it's one of this week's biggest winners. 
Via The Motley Fool
News headline image
LianBio Announces Presentation of Data from Phase 2a Study of Infigratinib in Patients with Gastric Cancer at ESMO Congress 2023
From LianBio
Via GlobeNewswire
News headline image
Raymond James Maintains Outperform Rating for LianBio: Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Tuesday. The Dow traded up 0.67% to 33,155.68 while the NASDAQ rose 0.78% to 13,120.31. The S&P... 
Via Benzinga
Topics Stocks
News headline image
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data. 
Via Benzinga
News headline image
Why Is LianBio (LIAN) Stock Up 130% Today? ↗
With LianBio inking a key exclusive licensing agreement with Bristol-Myers Squibb, LIAN stock is jumping up on the credibility implications. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Down Over 2%; General Motors Posts Upbeat Earnings ↗
U.S. stocks traded slightly higher midway through trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.17% to 32,992.95 while the NASDAQ rose 0.06% to 13,023.65.... 
Via Benzinga
Topics Stocks
News headline image
Why LianBio Stock Is Ripping Higher Today ↗
LianBio (NASDAQ: LIAN) shares are trading higher Tuesday after the company announced an agreement with Bristol Myers Squibb (NYSE: BMY) to purchase LianBio's exclusive rights to develop and... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.